# Comparing Different Routes and Doses of Phytonadione (Vitamin K) for Reversing Warfarin Treated Patients With Hip Fracture Before Surgery

> **NCT00905229** · NA · WITHDRAWN · sponsor: **HaEmek Medical Center, Israel**

## Conditions studied

- Bleeding
- Complications

## Interventions

- **DRUG:** Phytonadione
- **DRUG:** Phytonadione

## Key facts

- **NCT ID:** NCT00905229
- **Lead sponsor:** HaEmek Medical Center, Israel
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2009-05
- **Primary completion:** 2010-04
- **Final completion:** 2010-04
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Enrollment problems
- **Last updated:** 2015-06-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00905229

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00905229, "Comparing Different Routes and Doses of Phytonadione (Vitamin K) for Reversing Warfarin Treated Patients With Hip Fracture Before Surgery". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT00905229. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*